Chicago Dept. of Public Health - Health Alert

January 14, 2019

Verona Integron-mediated Metallo-Β-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) infections among adult patients returning to the United States after undergoing invasive procedures

Chicago Department of Public Health - Health Alert - Download PDF 

Summary and Action Items:
  • Providers caring for patients with a history of recent invasive procedures in Mexico should be aware of the potential for infections caused by resistant pathogens like VIM-CRPA.
  • Report to the Chicago Department of Public Health (CDPH) any carbapenem-resistant P. aeruginosa surgical site infections in patients following invasive procedures in Mexico.
  • Patients admitted to healthcare facilities in the U.S. following an overnight stay in a healthcare facility outside the U.S. (within the last 6 months) should undergo rectal screening for carbapenemase-producing organisms.
  • Mechanism testing for carbapenem-resistant Enterobacteriaceae (CRE) and CRPA is available free of charge via the Antibiotic Resistance Laboratory Network. Please contact CDPH prior to submission to obtain approval and a submission code. Email or contact Massimo Pacilli at 312-746-6225.

The News Article appears in the following categories: